RE:MCNA most effective drug Increasing Shareholder Value (Share Price)
If like me you believe that a PP is their top priority than don't expect anything that will jeapordize that, particularly a rebuttal, much less a corporate update. No news flow and still a financing as the most recent story. Why would anyone buy here when a financing is obviously on the way. The idea of a partnership or sale is clearly out of the realm of possibility until more cheap paper can be handed out. 2 months away from BLA submission and trading at a 1/10 the value of P1 peers. Good effort fellas!